• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

健康与疾病中的饮食与肠道微生物群

Diet and Gut Microbiota in Health and Disease.

作者信息

Shen Ting-Chin David

机构信息

Division of Gastroenterology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

出版信息

Nestle Nutr Inst Workshop Ser. 2017;88:117-126. doi: 10.1159/000455220. Epub 2017 Mar 27.

DOI:10.1159/000455220
PMID:28346928
Abstract

Gut microbiota plays an important role in host health maintenance and disease pathogenesis. The development of a stable and diverse gut microbiota is essential to various host physiologic functions such as immunoregulation, pathogen prevention, energy harvest, and metabolism. At the same time, a dysbiotic gut microbiota associated with disease is altered in structure and function, and often characterized by a decrease in species richness and proliferation of pathogenic bacterial taxa. As a shared substrate between the host and the gut microbiota, diet significantly impacts the health and disease states of the host both directly and through gut microbial metabolite production. This is demonstrated in the examples of short-chain fatty acid and trimethylamine production via bacterial metabolism of dietary complex carbohydrates and choline, respectively. In disorders related to mucosal immune dysregulation such as inflammatory bowel disease, the dysbiotic gut microbiota and diet contribute to its pathogenesis. Reversal of dysbiosis through fecal microbiota transplantation and dietary interventions may thus represent important strategies to modify the gut microbiota and its metabolite production for health maintenance as well as disease prevention and management.

摘要

肠道微生物群在宿主健康维持和疾病发病机制中发挥着重要作用。稳定且多样的肠道微生物群的发育对于各种宿主生理功能至关重要,如免疫调节、病原体预防、能量获取和代谢。同时,与疾病相关的失调肠道微生物群在结构和功能上发生改变,其特征通常是物种丰富度降低和致病细菌类群增殖。作为宿主和肠道微生物群之间的共享底物,饮食通过直接作用以及肠道微生物代谢产物的产生,对宿主的健康和疾病状态产生显著影响。这分别通过膳食复合碳水化合物和胆碱的细菌代谢产生短链脂肪酸和三甲胺的例子得到证明。在与黏膜免疫失调相关的疾病如炎症性肠病中,失调的肠道微生物群和饮食促成了其发病机制。因此,通过粪便微生物群移植和饮食干预来逆转失调可能代表着重要策略,以改变肠道微生物群及其代谢产物的产生,从而维持健康以及预防和管理疾病。

相似文献

1
Diet and Gut Microbiota in Health and Disease.健康与疾病中的饮食与肠道微生物群
Nestle Nutr Inst Workshop Ser. 2017;88:117-126. doi: 10.1159/000455220. Epub 2017 Mar 27.
2
Contributory Role of Gut Microbiota and Their Metabolites Toward Cardiovascular Complications in Chronic Kidney Disease.肠道微生物群及其代谢物对慢性肾脏病心血管并发症的贡献作用。
Semin Nephrol. 2018 Mar;38(2):193-205. doi: 10.1016/j.semnephrol.2018.01.008.
3
The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases.饮食中胆碱的生物利用度与其对肠道微生物组成的关系,及其对人类疾病的调节作用。
Nutrients. 2020 Aug 5;12(8):2340. doi: 10.3390/nu12082340.
4
Gut microbiota in the pathogenesis of inflammatory bowel disease.肠道微生物群在炎症性肠病发病机制中的作用
Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29.
5
Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.目前对微生物群和饮食疗法治疗炎症性肠病的理解。
J Microbiol. 2018 Mar;56(3):189-198. doi: 10.1007/s12275-018-8049-8. Epub 2018 Feb 28.
6
Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.肠道微生物群组成可调节饮食中胆碱的生物利用度以及促动脉粥样硬化代谢物氧化三甲胺的积累。
mBio. 2015 Mar 17;6(2):e02481. doi: 10.1128/mBio.02481-14.
7
Impaired renal function and dysbiosis of gut microbiota contribute to increased trimethylamine-N-oxide in chronic kidney disease patients.肾功能受损和肠道微生物群落失调导致慢性肾脏病患者中三甲胺-N-氧化物水平升高。
Sci Rep. 2017 May 3;7(1):1445. doi: 10.1038/s41598-017-01387-y.
8
The gut microbiome, diet, and links to cardiometabolic and chronic disorders.肠道微生物组、饮食与心血管代谢和慢性疾病的关联。
Nat Rev Nephrol. 2016 Mar;12(3):169-81. doi: 10.1038/nrneph.2015.191. Epub 2015 Nov 30.
9
[Intestinal immune response is regulated by gut microbe].肠道免疫反应受肠道微生物调节。
Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):408-415. doi: 10.2177/jsci.40.408.
10
Human microbiome restoration and safety.人类微生物组修复与安全性。
Int J Med Microbiol. 2018 Jul;308(5):487-497. doi: 10.1016/j.ijmm.2018.05.002. Epub 2018 May 9.

引用本文的文献

1
Fecal microbiota live - jslm (Rebyota™/RBL) for management of recurrent infection.用于治疗复发性感染的粪便微生物群活菌制剂-jslm(Rebyota™/RBL)
Future Microbiol. 2024;19(14):1243-1251. doi: 10.1080/17460913.2024.2364583. Epub 2024 Jul 11.
2
Review: A Contemporary, Multifaced Insight into Psoriasis Pathogenesis.综述:对银屑病发病机制的当代多面洞察
J Pers Med. 2024 May 16;14(5):535. doi: 10.3390/jpm14050535.
3
Synergistic Effect of Retinoic Acid and Lactoferrin in the Maintenance of Gut Homeostasis.视黄酸与乳铁蛋白在维持肠道内稳态中的协同作用。
Biomolecules. 2024 Jan 8;14(1):78. doi: 10.3390/biom14010078.
4
Electroacupuncture Improves Insulin Resistance in Type 2 Diabetes Mice by Regulating Intestinal Flora and Bile Acid.电针通过调节肠道菌群和胆汁酸改善2型糖尿病小鼠的胰岛素抵抗
Diabetes Metab Syndr Obes. 2023 Dec 7;16:4025-4042. doi: 10.2147/DMSO.S421134. eCollection 2023.
5
The benefits of edible mushroom polysaccharides for health and their influence on gut microbiota: a review.食用菌多糖对健康的益处及其对肠道微生物群的影响:综述
Front Nutr. 2023 Jul 6;10:1213010. doi: 10.3389/fnut.2023.1213010. eCollection 2023.
6
Changes in gut microbiota linked to a prevention of cardiac remodeling induced by hypertension in spontaneously hypertensive rats fed a pawpaw fruit diet.在喂食木瓜果实饮食的自发性高血压大鼠中,肠道微生物群的变化与预防高血压诱导的心脏重塑有关。
Heliyon. 2023 Apr 17;9(5):e15576. doi: 10.1016/j.heliyon.2023.e15576. eCollection 2023 May.
7
Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration.自噬调节中的肠道微生物群:神经退行性疾病的新治疗视角
Life (Basel). 2023 Apr 6;13(4):957. doi: 10.3390/life13040957.
8
COVID-19 and the Human Gut Microbiome: An Under-Recognized Association.新型冠状病毒肺炎与人类肠道微生物群:一种未被充分认识的关联。
Chonnam Med J. 2022 Sep;58(3):96-101. doi: 10.4068/cmj.2022.58.3.96. Epub 2022 Sep 23.
9
Synbiotics and Gut Microbiota: New Perspectives in the Treatment of Type 2 Diabetes Mellitus.合生元与肠道微生物群:2型糖尿病治疗的新视角
Foods. 2022 Aug 13;11(16):2438. doi: 10.3390/foods11162438.
10
Gut-Skin Axis: Unravelling the Connection between the Gut Microbiome and Psoriasis.肠-皮肤轴:揭示肠道微生物群与银屑病之间的联系
Biomedicines. 2022 Apr 30;10(5):1037. doi: 10.3390/biomedicines10051037.